Theo-dur and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Theo-dur (theophylline) and Meropenem (meropenem). Common drug interactions include cardiac failure among females and altered state of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Theo-dur and Meropenem. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Theo-dur?

Theo-dur has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 4,451 Theo-dur users. Check the latest studies of Theo-dur.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

11 people who take Theo-dur and Meropenem together, and have interactions are studied.

Theo-dur and Meropenem drug interactions.

What are the common drug interactions of Theo-Dur and Meropenem, by gender? *:

female:

  1. Cardiac failure
  2. Dehydration (dryness resulting from the removal of water)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Pneumonia
  6. Pseudomembranous colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon)
  7. Systemic mycosis (fungal infections of the body)
  8. Nephritis (inflammation of the nephrons in the kidneys)
  9. Pyelonephritis (inflammation of kidney caused by bacteria)

male:

  1. Altered state of consciousness (altered state of mind)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Alanine aminotransferase increased
  4. Aphasia (damage to the parts of the brain that control language)
  5. Aspartate aminotransferase increased
  6. Blood alkaline phosphatase increased
  7. Cerebral infarction (less blood supply to brain resulting tissue damage)
  8. Contrast media reaction (reaction associated with the use of intravenous contrast material during radiology)
  9. Diarrhoea
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Theo-Dur and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cardiac failure
  2. Pneumonia
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Restlessness (not able to rest)
  5. Septic shock (shock due to blood infection)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Death
  8. Nephritis (inflammation of the nephrons in the kidneys)
  9. Pyelonephritis (inflammation of kidney caused by bacteria)
  10. Alanine aminotransferase increased

What are the existing conditions these people have? *

  1. Pneumonia: 3 people, 27.27%
  2. Abdominal Abscess (collection of pus in abdomen): 2 people, 18.18%
  3. Gastric Ulcer (stomach ulcer): 2 people, 18.18%
  4. Spinal Compression Fracture (fracture due to spinal compression on bone): 2 people, 18.18%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 18.18%
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 18.18%
  7. Mediastinitis (inflammation of the tissues in the mid-chest): 2 people, 18.18%
  8. Lung Disorder (lung disease): 2 people, 18.18%
  9. Cardiac Failure: 2 people, 18.18%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Theo-dur and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Theo-dur and Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Theo-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Theo-dur and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meropenem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on theophylline and meropenem (the active ingredients of Theo-dur and Meropenem, respectively), and Theo-dur and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: